Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies
- 1 June 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 84 (2), 322-328
- https://doi.org/10.1111/j.1365-2141.1993.tb03072.x
Abstract
Summary. Heparin-induced thrombocytopenia is one of the most common and important immunological complications of drug therapy. Most patients with heparin-induced thrombocytopenia have isolated thrombocytopenia, which by itself seldom causes serious morbidity. However, a small proportion of patients also develop an acute arterial thrombotic episode which can be fatal. It remains uncertain why some patients have only isolated thrombocytopenia, whereas others have thrombotic complications. In this report we describe 53 patients with heparin-induced thrombocytopenia in whom the diagnosis was confirmed using the platelet 14C-serotonin release assay. The intent of the study was to look for laboratory or clinical characteristics that could be used to predict which patients will have the less serious thrombocytopenia and which patients will have thrombocytopenia plus thrombotic complications. The laboratory markers included AT-III, protein C, protein S and heparin cofactor II. No serological result identified whether a patient was at risk of having isolated thrombocytopenia or an acute thrombotic event. However, during the acute thrombocytopenic episode, there was evidence of global activation of the coagulation cascade as evidenced by reductions in the level of protein C, heparin cofactor II and antithrombin III. Following resolution of the thrombocytopenia, these inhibitory factors returned to normal indicating that the thrombotic complications were not caused by a familial deficiency. We did observe a highly significant association (P < 0·001) between concomitant cardiovascular complications and the occurrence of an arterial thrombosis in patients with heparin-induced thrombocytopenia. Recent surgery of any type was strongly associated with venous thrombi (P < 0·001). Our data suggest that heparin-induced thrombocytopenia is a procoagulant disorder with thrombosis tending to occur at sites of pre-existing pathology.Keywords
This publication has 19 references indexed in Scilit:
- Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with plateletsBritish Journal of Haematology, 1989
- Immune Endothelial-Cell Injury in Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1987
- Heparin-induced thrombocytopenia: A prospective study of 142 patientsJournal of Vascular Surgery, 1985
- Heparin-Associated ThrombocytopeniaTherapeutic Drug Monitoring, 1983
- White Clot SyndromeArchives of Surgery, 1979
- Heparin Induced ThrombocytopeniaAnnals of Surgery, 1977
- Thrombocytopenia Occurring During the Administration of HeparinAnnals of Internal Medicine, 1976
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- Antigen-antibody crossed electrophoresisAnalytical Biochemistry, 1965
- Arterial Embolism Occurring During Systemic Heparin TherapyArchives of Surgery, 1958